Journal: Bone & Joint Research
Article Title: Unravelling lumbar disc herniation severity beyond MRI
doi: 10.1302/2046-3758.145.BJR-2024-0071.R1
Figure Lengend Snippet: The protein and messenger RNA (mRNA) expression level of lysophospholipid acyltransferase 3 (LPCAT3) and PCYT1A in the severe and mild groups. a) to c) Representative western blot strips of LPCAT3 and PCYT1A in the severe and mild groups with quantitative analysis (n = 3). d) and e) Quantitative real-time polymerase chain reaction (qRT-PCR) results of LPCAT3 and PCYT1A in the lumbar disc herniation (LDH) patients with mild and severe symptoms with relative quantitative analysis (n = 3). f) and g) Enzyme-linked immunosorbent assay (ELISA) results of LPCAT3 and PCYT1A with quantitative analysis (n = 3). Independent-samples t -test was used for comparison: *p < 0.05, **p < 0.01, ***p < 0.001. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Article Snippet: Primary antibodies, including anti-lysophospholipid acyltransferase 3 (LPCAT3) antibody (1:500, 67882-1-Ig; Proteintech, USA), anti-phosphate cytidylyltransferase 1, choline, alpha (PCYT1A) antibody (1:500, NBP1-84366; NOVUS, USA), and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1:1,000, 10494-1-AP; Proteintech), were incubated overnight.
Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Comparison